Sanginita Chemicals Intrinsic Value
Sanginita Chemicals (SANGINITA) median intrinsic value is ₹21.54 from 4 valuation models (range ₹9–₹29), vs current price ₹14.55 — +48.0% upside (Trading Below Calculated Value), margin of safety 32.5%. For current market price and key ratios, visit Sanginita Chemicals share price today.
SANGINITA Valuation Methods Summary — DCF, Graham Number & P/E
Sanginita Chemicals intrinsic value across 4 models vs current price ₹14.55 — upside/downside and value range per method. Browse Sanginita Chemicals annual reports for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹21.54 | ₹19.39 - ₹23.69 | +48.0% | Book Value/Share: ₹21.54, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹29.10 | ₹26.19 - ₹32.01 | +100.0% | Revenue/Share: ₹77.69, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹9.23 | ₹8.31 - ₹10.15 | -36.6% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹10.71 | ₹8.57 - ₹12.85 | -26.4% | CF Growth: 5.0%, Discount: 15% |
SANGINITA Intrinsic Value vs Market Price — All Valuation Models
Sanginita Chemicals fair value range ₹9–₹29 vs current market price ₹14.55 across 4 valuation models. Compare with SANGINITA stock valuation models to assess whether the stock is under or overvalued.
SANGINITA Intrinsic Value Analysis — Undervalued or Overvalued?
Sanginita Chemicals median intrinsic value ₹21.54, current price ₹14.55 — Trading Below Calculated Value by 48.0%, margin of safety 32.5%.
What is the intrinsic value of SANGINITA?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Sanginita Chemicals (SANGINITA) is ₹21.54 (median value). With the current market price of ₹14.55, this represents a +48.0% variance from our estimated fair value.
The valuation range spans from ₹9.23 to ₹29.10, indicating ₹9.23 - ₹29.10.
Is SANGINITA undervalued or overvalued?
Based on our multi-method analysis, Sanginita Chemicals (SANGINITA) appears to be trading below calculated value by approximately 48.0%.
SANGINITA Financial Health — Key Ratios vs Industry Benchmarks
Sanginita Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 87.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.82 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -1.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.98x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SANGINITA Cash Flow Quality — Operating & Free Cash Flow
Sanginita Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹3 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-2 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹14 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-3 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |